Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna M Geretti

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of STD & AIDS|August 2, 2015
BASHH/EAGA position statement on the HIV window periodDaniel P Webster, Matthew Donati, Anna M Geretti, et al.
Antiviral Therapy|December 3, 2008
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapyAnna M Geretti, Colette Smith, Annette Haberl, et al.
Clinical Medicine (London, England)|November 17, 2020
<i>Pneumocystis</i> pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19Sophie Kelly, Laura Waters, Muge Cevik, et al.
AIDS (London, England)|August 10, 2012
Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West AfricaDavid Chadwick, Alastair Stanley, Stephen Sarfo, et al.
AIDS (London, England)|October 26, 2013
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adultsNicola E Mackie, David T Dunn, David Dolling, et al.
AIDS (London, England)|March 20, 2010
Long-term trends in adherence to antiretroviral therapy from start of HAARTValentina Cambiano, Fiona C Lampe, Alison J Rodger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2025
Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral RegimensJosep M Llibre, Diego Ripamonti, Anna M Geretti, et al.
AIDS (London, England)|October 17, 2018
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapyAnna Schultze, Carlo Torti, Alessandro Cozzi-Lepri, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of STD & AIDS|August 2, 2015
BASHH/EAGA position statement on the HIV window periodDaniel P Webster, Matthew Donati, Anna M Geretti, et al.
Antiviral Therapy|December 3, 2008
Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapyAnna M Geretti, Colette Smith, Annette Haberl, et al.
Clinical Medicine (London, England)|November 17, 2020
<i>Pneumocystis</i> pneumonia, a COVID-19 mimic, reminds us of the importance of HIV testing in COVID-19Sophie Kelly, Laura Waters, Muge Cevik, et al.
AIDS (London, England)|August 10, 2012
Response to antiretroviral therapy in occult hepatitis B and HIV co-infection in West AfricaDavid Chadwick, Alastair Stanley, Stephen Sarfo, et al.
AIDS (London, England)|October 26, 2013
The impact of HIV-1 reverse transcriptase polymorphisms on responses to first-line nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-1-infected adultsNicola E Mackie, David T Dunn, David Dolling, et al.
AIDS (London, England)|March 20, 2010
Long-term trends in adherence to antiretroviral therapy from start of HAARTValentina Cambiano, Fiona C Lampe, Alison J Rodger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2025
Emergent Human Immunodeficiency Virus Type 1 (HIV-1) Drug Resistance in Randomized Trials of Contemporary Antiretroviral RegimensJosep M Llibre, Diego Ripamonti, Anna M Geretti, et al.
AIDS (London, England)|October 17, 2018
The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapyAnna Schultze, Carlo Torti, Alessandro Cozzi-Lepri, et al.
Pageof 1